198. Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical Trial.
作者: Chan Joo Lee.;Sang-Hyun Ihm.;Dong-Ho Shin.;Jin-Ok Jeong.;Ju Han Kim.;Kyeong-Hyeon Chun.;JiWung Ryu.;Hae-Young Lee.;Seonghoon Choi.;Eun Mi Lee.;Jung Hyun Choi.;Kwang-Il Kim.;Jinho Shin.;Wook Bum Pyun.;Dae-Hee Kim.;Sungha Park.;Bryan Williams.
来源: JAMA. 2025年333卷23期2073-2082页
Amiloride has been proposed as an alternative to spironolactone for treating resistant hypertension. However, no randomized clinical trials have compared the efficacy of spironolactone and amiloride in patients with resistant hypertension.
|